Latest stories on CTNM
Contineum Therapeutics Updates Strategy, Highlights PIPE-791 Leadership
TipRanks55 · neutralgeneral
Contineum Therapeutics, Inc. (CTNM) files 8-K
SEC 8-K50 · neutralgeneral
Contineum Therapeutics, Inc. (CTNM) files 8-K
SEC 8-K50 · neutralgeneral
Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference | CTNM Stock News
StockTitan55 · neutralgeneral
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Morningstar50 · neutralgeneral